Cargando…
Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy
Atrasentan is a promising therapy for treating diabetic nephropathy (DN). Here we evaluated whether atrasentan down-regulated the miR-199b-5p expression, thereby increasing klotho and preventing renal tubular injury in DN. One-hundred patients with type 2 diabetes mellitus (T2DM) and 40 healthy subj...
Autores principales: | Kang, Wen-Ling, Xu, Gao-Si |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728478/ https://www.ncbi.nlm.nih.gov/pubmed/26813039 http://dx.doi.org/10.1038/srep19979 |
Ejemplares similares
-
Corrigendum: Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy
por: Kang, Wen-Ling, et al.
Publicado: (2018) -
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2019) -
Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho
por: He, Xu-Jun, et al.
Publicado: (2014) -
miR-199a and miR-199b facilitate diffuse gastric cancer progression by targeting Frizzled-6
por: Hong, Soon Auck, et al.
Publicado: (2023) -
Retraction Note: Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho
por: He, Xu-Jun, et al.
Publicado: (2022)